Pharmaceutical Investing DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer
Q Biomed Inc. Finalizes License Agreement With Oklahoma Medical Research Foundation And The Rajiv Gandhi Centre For Biotechnology For Novel Liver Cancer Treatment
